Therapeutics
SB 202026
Quick Links
Overview
Name: SB 202026
Synonyms: Memric
Chemical Name: Sabcomeline
Therapy Type: Small Molecule (timeline)
Target Type: Other Neurotransmitters (timeline)
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Discontinued)
Background
SB 202026 is a selective muscarinic M1 receptor partial agonist.
Last Updated: 16 Dec 2013
References
No Available References
Further Reading
No Available Further Reading
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.